Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review

Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review

Venous thromboembolism (VTE) is frequent among patients with cancer. Ambulatory cancer patients starting chemotherapy have a 5% to 10% risk of cancer associated thrombosis (CAT) within the first year after cancer diagnosis. This risk may vary according to patient characteristics, cancer location, ca...

Full description

Bibliographic Details
Main Authors:	Anne Rossel, Helia Robert-Ebadi, Christophe Marti
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Cancers
Subjects:	cancer associated thrombosis vte venous thromboembolism malignancy low molecular weight heparin direct oral anticoagulant
Online Access:	https://www.mdpi.com/2072-6694/12/3/612

Similar Items

Evolving Treatment Options for Cancer-Related Venous Thromboembolism∗
by: Doaa Attia, MD, et al.
Published: (2020-09-01)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
by: Maha Al-Ghafry, et al.
Published: (2022-10-01)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
by: Hanny Al-Samkari, et al.
Published: (2018-08-01)

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism
by: Wumaier K, et al.
Published: (2022-08-01)

Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
by: Alannah Smrke, et al.
Published: (2017-08-01)

Direct oral anticoagulants in cancer-associated venous thromboembolism
by: Kirill Lobastov, et al.
Published: (2020-01-01)

The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
by: К. V. Lobastov, et al.
Published: (2020-05-01)

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner
by: Amye M. Harrigan, et al.
Published: (2022-09-01)

Primary Thromboprophylaxis for the Prevention of Venous Thromboembolism in Cancer Patients with Central Venous Catheters: A Literature Review
by: Hikmat Abdel-Razeq, et al.
Published: (2024-03-01)

Venous Thromboembolism in Pregnancy: Challenges and Solutions
by: Varrias D, et al.
Published: (2023-07-01)

Occurrence of Venous Thromboembolism in Patients with Lung Cancer  and Its Anticoagulant Therapy
by: Hui DU, et al.
Published: (2018-10-01)

European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism
by: Carter Patrice, et al.
Published: (2024-03-01)

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
by: Frits I. Mulder, et al.
Published: (2020-02-01)

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
by: Alexander T. Cohen, et al.
Published: (2018-05-01)

Expanding the possibilities of treatment and prevention of venous thromboembolic complications in cancer patients. The role of oral anticoagulants
by: R. A. Bredikhin, et al.
Published: (2022-10-01)

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
by: U Vasudeva Rao, et al.
Published: (2021-01-01)

Editorial: COVID-19 and Venous Thromboembolism
by: Yugo Yamashita
Published: (2021-12-01)

A Cross-sectional Study of the Assessment of Venous Thromboembolism Risk and Use of Anticoagulant Thromboprophylaxis
by: Emile Abimana, et al.
Published: (2022-03-01)

Current Recommendations for the Management of Cancer-Associated Venous Thromboembolism
by: Makó Katalin
Published: (2021-06-01)

Descriptive Data of Patients with Venous Thromboembolism
by: Gul Ilhan
Published: (2013-08-01)

Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
by: Corinne Frere, et al.
Published: (2022-05-01)

Arguments for Using Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism
by: Roxana Mihaela Chiorescu, et al.
Published: (2021-09-01)

Predictors of pregnancy-associated venous thromboembolism: A case-control study
by: Mohammed A. Alsheef, et al.
Published: (2022-10-01)

Search for Venous Endothelial Biomarkers Heralding Venous Thromboembolism in Space: A Qualitative Systematic Review of Terrestrial Studies
by: Katie Harris, et al.
Published: (2022-04-01)

Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
by: Zygimantas Zaboras, et al.
Published: (2024-01-01)

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry
by: Paolo Prandoni, et al.
Published: (2022-05-01)

Clinical epidemiology of venous thromboembolic disease: An institutional registry
by: Mohammed AlSheef, et al.
Published: (2022-07-01)

Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
by: Agnes Y.Y. Lee
Published: (2024-02-01)

Sedentary work and risk of venous thromboembolism
by: Camilla Ditlev Lindhardt Johannesen, et al.
Published: (2020-01-01)

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
by: Elizabeth Joyce, et al.
Published: (2022-11-01)

Retrospective evaluation of chemical venous thromboembolism prophylaxis in traumatic brain injury
by: Emily K. Hollfelder, et al.
Published: (2023-06-01)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
by: Caroti Caroti, et al.
Published: (2023-07-01)

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis
by: Anthony Chan, et al.
Published: (2018-11-01)

How to Treat Today? Oral and Facial Cancer-Associated Venous Thromboembolism
by: Mária Janíčková, et al.
Published: (2023-07-01)

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
by: Kaidireyahan Wumaier, et al.
Published: (2021-09-01)

Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
by: Alhasson H, et al.
Published: (2021-11-01)

Reply: Pulmonary thromboembolism in an emergency hospital: Are our patients different?
by: Ioannou Petros
Published: (2018-03-01)

Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study
by: Verinder Sidhu, et al.
Published: (2023-08-01)

Review of Medical Therapies for the Management of Pulmonary Embolism
by: Ladan Panahi, et al.
Published: (2021-01-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
by: Sidrah Shah, et al.
Published: (2021-05-01)